DIA 2019 Global Annual Meeting
June 23-27, 2019 | San Diego, CA
|
The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s performance in the development ecosystem. |
Download the DIA 2019 Global Annual Meeting Schedule At-A-Glance for session times and to help plan out your days. Download >> |
Join Avoca for the Following Sessions:
Monday, June 24 | 11:00am – 12:00pm
Quality Management Post-Quality Management System Implementation In The Wake of ICH E6 (R2)
Component Type: Forum
Level: Intermediate
Chair: Jay Turpen, Senior Consultant, The Avoca Group
Learning Objectives: Discuss the differing characteristics of a QMS based on the size of the organization; Compare how these characteristics changed in preparation for ICH E6 R2 implementation; Determine whether risk-based approaches vary based on organizational size and what organizations of different sizes can learn from each other.
Panelists:
RJ Doornbos, Head of Global Quality Systems, Global Quality, BMS
Michael Husovich, Director, Global R&D Quality, Amgen Inc.
Lenna Kimball, Vice President of Clinical Operations, Lyell Biotech
Monday, June 24 | 3:30pm – 4:30pm
Compliance: The Importance of Periodic Screenings to Ensure Good Inspection Health
Component Type: Forum
Level: Intermediate
Learning Objectives: Demonstrate how periodic screenings are an important part of inspection readiness; Discuss where hidden challenges lurk and how mock inspections can bring these items to light; Identify appropriate remediation plans that are organizationally focused and not study specific.
Speakers:
Grace Crawford, Vice President, Clinical Quality and Compliance, MedImmune
Barbara Maley, Senior Consultant, The Avoca Group
Tuesday, June 25 | 8:00am – 9:15am
Component Type: Workshop
Level: Basic
Chair: Dawn Auerbach, Executive Director, Client Development, The Avoca Group
Learning Objectives: Identify your DISC personality type; Identify strategies for analyzing the situation from an alternative viewpoint/DISC type to facilitate change management and adoption; Discuss how personality type variations in clinical trial execution impact risk-based approach implementation and may be leveraged for success.
Speakers:
Jay Turpen, Senior Consultant, The Avoca Group
Bill Bennett, CEO, Empowering Leadership
Wednesday, June 26 | 4:15pm – 5:30pm
A New Path Forward for Using Decentralized Clinical Trials
Component Type: Forum
Level: Intermediate
Chair: Penny Randall, Vice President and Head, CNS Center of Excellence, IQVIA
Learning Objectives: Describe proven methods for executing decentralized clinical trials through telemedicine and mobile healthcare providers; Discuss actionable recommendations for navigating state medical licensing laws and issues with drug supply chain of custody; Identify the broad continuum of hybrid protocol designs possibilities for implementing decentralized clinical trials.
Panelists:
Gail Adinamis, CEO, GlobalCare Clinical Trials, LLC
Michael O’Brien, Chief Strategy Officer, Diligent Pharma
Laura Podolsky, General Counsel, Science 37, Inc.
To schedule a meeting with an Avoca representative at DIA 2019, contact us.